Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer
文献类型:期刊论文
作者 | Dou, Wei-Tao1,2,3; Qiu, Peng1,2,3; Shi, Yuanyuan4; Zhu, Ling1,2,3; Guo, Chen1,2,3; Li, Na5; Zang, Yi6,7![]() |
刊名 | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
![]() |
出版日期 | 2023-07-27 |
卷号 | 145期号:31页码:17377-17388 |
ISSN号 | 0002-7863 |
DOI | 10.1021/jacs.3c05052 |
通讯作者 | Sessler, Jonathan L.(Sessler@cm.utexas.edu) ; Tan, Yexiong(yxtan1214@163.com) ; Li, Jia(jli@simm.ac.cn) ; Wang, Hongyang(hywangk@vip.sina.com) ; He, Xiao-Peng(xphe@ecust.edu.cn) |
英文摘要 | The five-year survival rate of hepatocellular carcinoma(HCC) remainsunsatisfactory. This reflects, in part, the paucity of effective methodsthat allow the target-specific diagnosis and therapy of HCC. Here,we report a strategy based on engineered human serum albumin (HSA)that permits the HCC-targeted delivery of diagnostic and therapeuticagents. Covalent cysteine conjugation combined with the exploitationof host-guest chemistry was used to effect the orthogonal functionalizationof HSA with two functionally independent peptides. One of these peptidestargets glypican-3 (GPC-3), an HCC-specific biomarker, while the secondreduces macrophage phagocytosis through immune-checkpoint stimulation.This orthogonally engineered HSA proved effective for the GPC-3-targeteddelivery of near-infrared fluorescent and phototherapeutic agents,thus permitting target-specific optical visualization and photodynamicablation of HCC in vivo. This study thus offers new insights intospecificity-enhanced fluorescence-guided surgery and phototherapyof HCC through the orthogonal engineering of biocompatible proteins. |
WOS关键词 | HEPATOCELLULAR-CARCINOMA ; BIOMARKER DISCOVERY ; CELLS ; DOXORUBICIN ; GLYPICAN-3 ; DIAGNOSIS ; BINDING |
资助项目 | National Natural Science Foundation of China[92253306] ; National Natural Science Foundation of China[82130099] ; National Natural Science Foundation of China[22107028] ; National Natural Science Foundation of China[U2230115] ; Shanghai Municipal Science and Technology Major Project[2018SHZDZX03] ; Science and Technology Commission of Shanghai Municipality[20JC1419400] ; Open Funding Project of the State Key Laboratory of Bioreactor Engineering of East China University of Science and Technology ; Fundamental Research Funds for the Central Universities[222201717003] ; Programme of Introducing Talents of Discipline to Universities[B16017] ; Robert A. Welch Foundation[F-0018] |
WOS研究方向 | Chemistry |
语种 | 英语 |
WOS记录号 | WOS:001037700000001 |
出版者 | AMER CHEMICAL SOC |
源URL | [http://119.78.100.183/handle/2S10ELR8/306833] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Sessler, Jonathan L.; Tan, Yexiong; Li, Jia; Wang, Hongyang; He, Xiao-Peng |
作者单位 | 1.East China Univ Sci & Technol, Frontiers Ctr Materiobiol & Dynam Chem, Sch Chem & Mol Engn, Key Lab Adv Mat, Shanghai 200237, Peoples R China 2.East China Univ Sci & Technol, Frontiers Ctr Materiobiol & Dynam Chem, Sch Chem & Mol Engn, Joint Int Res Lab Precis Chem & Mol Engn, Shanghai 200237, Peoples R China 3.East China Univ Sci & Technol, Joint Res Ctr, Frontiers Ctr Materiobiol & Dynam Chem, Sch Chem & Mol Engn, Shanghai 200237, Peoples R China 4.Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Natl Ctr Liver Canc, Int Cooperat Lab Signal Transduct, Shanghai 200433, Peoples R China 5.Chinese Acad Sci, Shanghai Adv Res Inst, Natl Facil Prot Sci Shanghai, Shanghai 201210, Peoples R China 6.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China 7.Lingang Lab, Shanghai 201203, Peoples R China 8.ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China 9.Univ Texas Austin, Dept Chem, Austin, TX 78712 USA |
推荐引用方式 GB/T 7714 | Dou, Wei-Tao,Qiu, Peng,Shi, Yuanyuan,et al. Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,2023,145(31):17377-17388. |
APA | Dou, Wei-Tao.,Qiu, Peng.,Shi, Yuanyuan.,Zhu, Ling.,Guo, Chen.,...&He, Xiao-Peng.(2023).Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,145(31),17377-17388. |
MLA | Dou, Wei-Tao,et al."Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of Liver Cancer".JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 145.31(2023):17377-17388. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。